In this issue:
Tenapanor + phosphate binders for hyperphosphataemia in dialysis patients
Vitamin K antagonists vs rivaroxaban in haemodialysis patients with AF
Initial effects of COVID-19 in patients with ESKD
Impact of intravenous radiocontrast on kidney function
Effects of intra-dialytic cycling on left ventricular mass
Longevity of SARS-CoV-2 immune responses in haemodialysis patients
Mineralocorticoid receptor antagonists in dialysis patients
Effect of haemodiafiltration on physical activity
Efficacy and safety of oral tolvaptan in patients undergoing haemodialysis
Please login below to download this issue (PDF)